<DOC>
	<DOCNO>NCT00159874</DOCNO>
	<brief_summary>Active treatment , dose-blinded extension study evaluate safety long term efficacy sildenafil citrate child PAH .</brief_summary>
	<brief_title>A Long Term Extension Study Evaluating Safety Of Sildenafil Citrate When Used To Treat Pulmonary Arterial Hypertension ( PAH ) In Children</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Sildenafil Citrate</mesh_term>
	<mesh_term>Citric Acid</mesh_term>
	<criteria>Patients must complete 16 Week doubleblind efficacy study A1481131 . Any patient complete Study A1481131 .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>child</keyword>
</DOC>